David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Snap
SNAP
|
+$362M |
| 2 |
Lockheed Martin
LMT
|
+$361M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$354M |
| 4 |
Fidelity National Information Services
FIS
|
+$354M |
| 5 |
Boston Scientific
BSX
|
+$337M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$559M |
| 2 |
Advanced Micro Devices
AMD
|
+$558M |
| 3 |
Boeing
BA
|
+$530M |
| 4 |
Lowe's Companies
LOW
|
+$525M |
| 5 |
Alibaba
BABA
|
+$420M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.94% |
| 2 | Consumer Discretionary | 10.41% |
| 3 | Healthcare | 9.22% |
| 4 | Communication Services | 7.29% |
| 5 | Financials | 6.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2926
Tanger
SKT
$4.45B
| $967K | ﹤0.01% |
97,117
-30,967
| -24% | -$262K |
|
|
DCPH
2927
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $967K | ﹤0.01% |
16,943
+5,921
| +54% | +$351K |
|
2928
PUT
Colgate-Palmolive
CL
$73.2B
| $966K | ﹤0.01% |
+11,300
| New | +$934K |
|
2929
Foster
FSTR
$397M
| $966K | ﹤0.01% |
64,210
-1,040
| -2% | -$15.3K |
|
|
ZEUS
2930
DELISTED
Olympic Steel
ZEUS
| $965K | ﹤0.01% |
72,370
+1,177
| +2% | +$15.8K |
|
2931
Horizon Technology Finance
HRZN
$322M
| $963K | ﹤0.01% |
+72,722
| New | +$908K |
|
2932
PUT
First Majestic Silver
AG
$10.3B
| $961K | ﹤0.01% |
71,500
| – | – |
|
2933
CALL
Enbridge
ENB
$109B
| $960K | ﹤0.01% |
30,000
| – | – |
|
2934
Hewlett Packard
HPE
$71.2B
| $957K | ﹤0.01% |
80,755
-1,820,016
| -96% | -$19.1M |
|
2935
PUT
Principal Financial Group
PFG
$23.8B
| $957K | ﹤0.01% |
19,300
| – | – |
|
2936
CALL
Tandem Diabetes Care
TNDM
$1.5B
| $957K | ﹤0.01% |
10,000
-10,000
| -50% | -$1.03M |
|
2937
SandRidge Energy
SD
$515M
| $955K | ﹤0.01% |
307,912
+59,589
| +24% | +$146K |
|
|
APRN
2938
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
| $955K | ﹤0.01% |
14,237
-7,966
| -36% | -$617K |
|
2939
Grocery Outlet
GO
$1.19B
| $950K | ﹤0.01% |
+24,196
| New | +$977K |
|
2940
Neurocrine Biosciences
NBIX
$15.5B
| $947K | ﹤0.01% |
9,880
-109,285
| -92% | -$10.6M |
|
|
AAWW
2941
CALL
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $944K | ﹤0.01% |
17,300
| – | – |
|
2942
CALL
Archer Daniels Midland
ADM
$36.9B
| $943K | ﹤0.01% |
+18,700
| New | +$924K |
|
2943
PUT
Carrier Global
CARR
$48.7B
| $943K | ﹤0.01% |
25,000
| – | – |
|
2944
Movado Group
MOV
$763M
| $943K | ﹤0.01% |
56,717
-10,287
| -15% | -$147K |
|
2945
NewMarket
NEU
$8.54B
| $939K | ﹤0.01% |
2,357
-287
| -11% | -$107K |
|
2946
Liberty Global Class C
LBTYK
$3.57B
| $938K | ﹤0.01% |
+39,667
| New | +$860K |
|
2947
CALL
GDS Holdings
GDS
$6.5B
| $936K | ﹤0.01% |
10,000
-58,500
| -85% | -$5.2M |
|
2948
Enanta Pharmaceuticals
ENTA
$436M
| $935K | ﹤0.01% |
22,209
-2,117
| -9% | -$93.1K |
|
2949
Saratoga Investment
SAR
$296M
| $929K | ﹤0.01% |
44,563
+11,401
| +34% | +$229K |
|
|
RMGBU
2950
DELISTED
RMG Acquisition Corp. II Unit
RMGBU
| $929K | ﹤0.01% |
+83,333
| New | +$888K |
|
Similar funds
David Shaw's Q4 2020 Portfolio in Review
As of Q4 2020, David Shaw held 4,343 positions worth $112B, up 14% from $97.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $10.3B in Q4 2020, closing 477 positions and reducing 1,508 holdings. Its most notable exit was iShares Gold Trust, an estimated $217M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, David Shaw opened a new position in Snowflake worth $147M.
- David Shaw's largest Q4 2020 buy was Snowflake: 523,721 shares worth $147M.
- David Shaw added most to Snap in Q4 2020, an estimated $362M increase.
- David Shaw's biggest Q4 2020 reduction was Tesla, cutting an estimated $559M.
- David Shaw fully exited iShares Gold Trust in Q4 2020, selling an estimated $217M.
- David Shaw's ten largest holdings make up 11% of its $112B portfolio in Q4 2020.
- David Shaw opened 563 new positions and closed 477 in Q4 2020.
- David Shaw's portfolio value rose 14% quarter-over-quarter to $112B.
Based on D.E. Shaw & Co's 13F filing for Q4 2020, filed 16 Feb 2021.